Xenon Pharmaceuticals (XENE) is upgraded to "Strong Buy" following positive phase 3 X-TOLE2 results

10x Genomics reported second-quarter revenue of $151 million, including $1.6 million in license and

Xenon posts a narrower-than-expected Q2 loss as azetukalner advances toward a planned FDA filing, wh

Xenon Pharmaceuticals Inc. (XENE) Q2 2026 Earnings Call Transcript

NDA submission for azetukalner on track for Q3 2026  following pre-NDA meeting with FDA Phase 3 X-TO

VANCOUVER, BC and BOSTON, MA, July 31, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:

VANCOUVER, BC and BOSTON, MA, July 30, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:

Bank of New York Mellon Corp grew its position in shares of Xenon Pharmaceuticals Inc. (NASDAQ: XENE

Castleark Management LLC purchased a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ: X

Xenon Pharmaceuticals (XENE) is transitioning into a late-stage, cash-rich neuroscience company with

VANCOUVER, British Columbia and BOSTON, MA, July 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals

XENE's shares climb 22% in six months as azetukalner delivers strong phase III epilepsy data and adv

VANCOUVER, British Columbia and BOSTON, MA, May 29, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals I

Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epile

Xenon Pharmaceuticals Inc. (XENE) Presents at Bank of America Global Healthcare Conference 2026 Tran

Xenon Pharmaceuticals NASDAQ: XENE said it is preparing to submit a new drug application to the U.S.

Xenon Pharmaceuticals Inc. (XENE) Q1 2026 Earnings Call Transcript

VANCOUVER, British Columbia and BOSTON, MA, May 07, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals I

Polarean highlights 20+ ATS 2026 presentations advancing Xenon MRI as a biomarker platform for trial

US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a

Upgrades

Upgrades

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly

  Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earn

  Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report e

  Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc

Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday afte

Gainers Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) shares jumped 98.40% to $2.5201 after the

Stocks That Hit 52-Week Highs On Friday

Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Friday

Stocks That Hit 52-Week Highs On Thursday

Stocks That Made New 52-Week Highs Yesterday, September 6th

42 Biggest Movers From Yesterday

41 Stocks Moving In Tuesday's Mid-Day Session